NCT00692224View on ClinicalTrials.gov

Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

294

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

Neonatal Jaundice

Interventions

DRUG

zinc gluconate

zinc gluconate syrup - 10mg/day in two divided doses from day 2 to day 7 of life

DRUG

placebo

placebo was packed in similar looking bottles and ad similar taste as zinc gluconate drug

Trial Locations (1)

110029

All India Institute Of Medical Sciences, New Delhi

All Listed Sponsors

lead

All India Institute of Medical Sciences

OTHER

NCT00692224 - Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial | Biotech Hunter | Biotech Hunter